CEFTRIAXONE 500mg. IP + SULBACTAM 250mg. IP

A broad-spectrum antibiotic that exhibits potent activity against Gram-positive and Gram-negative bacteria. (Boubakar Ba, 2018) A highly effective in treating gonococcal infections. (K Panikabutra C. A., 1985) An effective combination drug that restores a degree of antimicrobial activity against Pseudomonas aeruginosa and Acinetobacter baumannii. (Xiaojuan Xin, 2013) A potential alternative to cefoperazone/sulbactam for the treatment of infection caused by resistant species. (Xiaojuan Xin, 2013) Has better bactericidal properties and reduces the probability of resistance development. (S.M. Shrivastava, 2009) An effective and well-tolerated agent for the treatment of intermediate and severe bacterial infections caused by resistant strains. (Xiaojuan Xin, 2013) An important third-generation cephalosporin in the treatment of serious community-acquired and nosocomial infections. (Harriet M Lamb, 2002) Effective against various beta-lactamase-producing microbes. (Jambulingappa, 2015) More active than penicillin G against both beta-lactamase-positive and -negative strains of Neisseria gonorrhoeae. (Judson, 1986) Possesses a broad spectrum of antimicrobial activity against gram-positive and gram-negative aerobes commonly associated with serious infections. (R Davis, 1994) Offers an alternative for the treatment of serious infections due to multidrug-resistant Gram-negative bacteria. (D M Richards, 1984) A beneficial agent for treating serious gram-negative infections in seriously ill patients. (B E Scully, 1984)